Diabetes is a risk factor for the progression and prognosis of COVID‐19

By Wei-na Guo, Mingyue Li, Yalan Dong, Hai-feng Zhou, Zili Zhang, Chunxia Tian, Ren-jie Qin, Haijun Wang, Yin Shen, Keye Du and 4 more. Diabetes/Metabolism Research Reviews, 2020

1,400 citations recorded by the source corpus.

To figure out whether diabetes is a risk factor influencing the progression and prognosis of 2019 novel coronavirus disease (COVID‐19).

Subfields: Dermatology, Genetics, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/acc88052e4c007586d535af575671507787ffc4f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. R. Pranata
2. I. Huang

Citations in the corpus

• Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (2020, positive): “in their case-control study from China [30], in which they compared diabetic and non-diabetic COVID-19 patients, and found that even in absence of other comorbidities, diabetics were at higher risk of severe pneumonia, uncontrolled inflammatory response, higher levels of tissue injury-related enzyme”
• Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression (2020, positive): “It is not yet known whether people with DM are more susceptible to COVID-19, but several studies have reported a greater risk of severe COVID-19 in diabetic patients [3,4].”
• Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis (2020, positive): “diseases, and diabetes are among the main risk factors for severe COVID-19 symptoms (Guo et al., 2020; Jordan et al., 2020; Zhou et al., 2020; Zhu et al., 2020).”